GMRE Stock Cash Flow Statements

Global Medical REIT Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Global Medical REIT Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31

operating activities
net income	585,000	3,737,000	2,939,000	3,391,000	-1,952,000	2,314,000	551,000	4,833,000	14,177,000	2,173,000	1,848,000	10,029,000	3,833,000	4,286,000	5,487,000	5,368,000	4,164,000	3,323,000	2,592,000	-9,580,000	1,672,000	2,817,000	2,775,000	2,308,000	2,462,000	2,043,000	9,504,000	1,772,000	1,384,000	1,901,000	1,248,172	605,536	600,594	-2,541,302	-1,929,862	-1,982,826	-494,199	-1,946,563
adjustments to reconcile net income to net cash from operating activities:
depreciation expense	11,307,000	10,307,000	10,194,000	9,993,000	10,127,000	10,113,000	10,204,000	10,100,000	10,468,000	10,494,000	10,580,000	10,128,000	9,898,000	9,402,000	9,046,000	8,639,000	8,292,000	7,848,000	7,364,000	6,954,000	6,593,000	5,836,000	5,585,000	5,006,000	4,608,000	3,867,000	3,679,000	3,614,000	3,445,000	2,906,000	2,556,692	2,175,668	1,850,587	1,346,053	806,383	585,449	544,002	398,830
amortization of acquired lease intangible assets	3,759,000	3,287,000	3,312,000	3,545,000	3,766,000	3,863,000	3,973,000	4,039,000	4,306,000	4,373,000	4,491,000	4,265,000	4,116,000	3,755,000	3,585,000	3,281,000	3,113,000	2,984,000	2,754,000	2,544,000	2,348,000	1,921,000	1,812,000	1,500,000	1,255,000	1,002,000	980,000	954,000	926,000	765,000	745,605	523,487	459,308	343,600
amortization of above market leases	-60,000	452,000	389,000	282,000	249,000	251,000	240,000	234,000	287,000	291,000	292,000	221,000	315,000	199,000	202,000	173,000	85,000	60,000	32,000	69,000	156,000	247,000	247,000	229,000	186,000	219,000
amortization of debt issuance costs and other	559,000	559,000	559,000	559,000	563,000	562,000	581,000	593,000	601,000	601,000	601,000	571,000	514,000	515,000	514,000	538,000	505,000	425,000	420,000	396,000	319,000	315,000
stock-based compensation expense	1,728,000	151,000	1,276,000	1,274,000	1,319,000	1,233,000	1,222,000	1,185,000	1,147,000	688,000	1,066,000	1,039,000	1,289,000	1,287,000	1,242,000	1,241,000	1,612,000	1,715,000	1,928,000	1,572,000	897,000	922,000	843,000	868,000	854,000	771,000	693,000	741,000	1,055,000	182,000	315,276	340,287	720,827	419,610
capitalized preacquisition and other costs charged to expense			149,000	11,000	48,000	34,000	22,000	79,000	61,000	15,000	128,000	154,000	37,000	153,000
reserve for uncollectible accounts			0	0
(gain) loss on sale of investment properties
equity income from unconsolidated joint venture	51,000	40,000
other	45,000	25,000	7,000	-73,000	33,000	169,000	148,000	164,000			-47,000	23,000	16,000	29,000	24,000	16,000	12,000	10,000	-61,000	-1,000	20,000	26,000	23,000	12,000	37,000	33,000
changes in operating assets and liabilities:
tenant receivables	278,000	-680,000	698,000	-49,000	-1,152,000	-981,000	-87,000	-146,000	21,000	638,000	-1,658,000	-1,193,000	288,000	-407,000	-1,227,000	-240,000	799,000	11,000	870,000	-914,000	-807,000	-751,000	-910,000	-202,000	-376,000	-654,000	-1,161,000	-405,000	-86,000	-549,000	-87,694	-82,257	-187,374	-134,675	-35,066			-261,955
deferred assets	-479,000	-57,000	-905,000	257,000	-402,000	-863,000	-385,000	-747,000	-920,000	-811,000	-949,000	-1,076,000	-1,017,000	-1,297,000	-1,148,000	-1,372,000	-1,374,000	-1,404,000	-1,345,000	-1,495,000	-1,292,000	-1,629,000	-1,205,000	-1,476,000	-1,473,000	-1,006,000	-1,214,000	-1,962,000	-1,457,000	-1,178,000	-1,069,043	-1,056,484	-779,862	-382,611	-458,918	-90,905	211,003	-342,422
other assets and liabilities	928,000	-2,987,000	3,022,000	-739,000	742,000	-1,033,000	1,329,000	-563,000	-14,000	-210,000	1,396,000	-1,133,000	855,000	-532,000	1,391,000	-1,384,000	-546,000	551,000
accounts payable and accrued expenses	3,570,000	-1,254,000	2,830,000	425,000	1,785,000	-2,057,000	-1,168,000	-516,000	884,000	-1,223,000	503,000	1,939,000	2,651,000	-1,030,000	-1,032,000	2,094,000	1,149,000	-287,000	393,000	-2,451,000	1,569,000	2,051,000	-54,000	933,000	612,000	-634,000	85,000	180,000	-580,000	1,834,000	-267,426	228,257	35,576	1,358,593
security deposits	33,000	50,000	102,000	-751,000	-403,000	688,000	-225,000	-300,000	-475,000	-773,000	57,000	100,000	688,000	76,000	-60,000	215,000	18,000	27,000																1,380,252	121,999	278,094	0	319,499
net cash from operating activities	22,139,000	12,272,000	20,523,000	16,302,000	18,928,000	14,293,000	18,125,000	16,666,000	17,878,000	15,771,000	18,308,000	18,314,000	23,483,000	16,436,000	17,283,000	18,608,000	17,789,000	15,287,000	16,131,000	-5,479,000	11,608,000	12,260,000	9,746,000	10,017,000	10,516,000	6,148,000	5,734,000	4,177,000	5,628,000	9,295,000	4,324,847	3,463,870	2,994,847	819,436	-663,366	-1,854,974	910,821	-1,115,647

investing activities
purchase of land, buildings, and other tangible and intangible assets and liabilities	-38,490,000	-31,978,000	-50,395,000				0	0			-335,000	-50,675,000	-75,449,000	-24,468,000	-26,512,000	-50,198,000	-72,197,000	-43,348,000	-80,862,000	-60,756,000	-7,600,000	-68,457,000	-73,545,000	-65,968,000	-94,631,000	-20,841,000	-46,986,000	-8,977,000	-59,309,000	-65,565,000	-38,684,539	-65,060,983	-40,407,660	-108,066,818
net proceeds from sale of investment properties	1,328,000	7,783,000	38,138,000	11,693,000			990,000	9,526,000
distribution of capital from unconsolidated joint venture	25,000	33,000
escrow deposits for purchase of properties	476,000	-186,000	962,000	-752,000						-153,000	400,000	492,000	490,000	-1,284,000	781,000	-225,000	720,000	300,000	-520,000	200,000	600,000	-100,000	-475,000	725,000	-150,000	-1,472,000	948,000	-476,000	500,000	-798,000	-292,000	-309,448	1,557,772	-1,308,324	-290,000	50,000	-50,000	394,310
advances made to related parties	-41,000	-150,000		6,000	-47,000	-170,000		102,000	-70,000	-121,000		0	114,000	-288,000
capital expenditures on existing real estate investments	-1,965,000	-2,611,000	-3,473,000	-4,766,000	-3,202,000	-2,004,000	-3,826,000	-3,445,000	-1,524,000	-809,000	-1,611,000	-2,154,000	-953,000	-556,000	-7,785,000	-336,000	-887,000	-397,000	-696,000	-75,000	-130,000	-211,000	-1,487,000	-144,000	-184,000	-9,000
leasing commissions	-558,000	-115,000	-2,803,000	-390,000	-2,003,000	-542,000	-374,000	-519,000
net cash from investing activities	-39,225,000	-27,224,000	-19,523,000	-25,488,000	1,785,000	-2,716,000	-3,114,000	5,664,000	61,974,000	3,092,000	-1,410,000	-33,448,000	-75,798,000	-26,596,000	-27,925,000	-50,769,000	-72,399,000	-43,572,000	-82,060,000	-65,653,000	-7,196,000	-68,763,000	-75,523,000	-65,200,000	-94,819,000	-22,655,000	-15,187,000	-10,860,000	-59,321,000	-66,250,000	-39,147,426	-65,441,619	-38,814,553	-109,249,402	-82,022,402	-30,694,316	-67,540	-37,573,329
financing activities
escrow deposits required by third party lenders		-18,000	21,000	-17,000	312,000	-64,000	8,198,000	-136,000	-263,000	-639,000	-573,000	-444,000	-501,000	-456,000	-768,000	-214,000	-1,088,000	-646,000	-505,000	-649,000	-313,000	-72,000	-77,000	-72,000	-72,000	-72,000	-72,000	-72,000	-72,000	-72,000	-48,512	-8,508	-8,485	-8,495	-18,541	-8,474	-5,643	-829,519
repayment of notes payable	-104,000	-160,000	-103,000	-154,000	-11,057,000	-230,000	-298,000	-336,000	-284,000	-344,000	-285,000	-321,000	-270,000	-282,000	-272,000	-7,285,000	-256,000	-190,000	-186,000	-120,000
proceeds from credit facility	50,500,000	44,000,000	61,000,000	44,300,000	24,500,000	14,000,000	45,000,000	13,500,000	12,000,000	12,600,000	11,500,000	34,600,000	78,400,000	14,100,000	33,900,000	54,600,000	83,000,000	50,100,000	80,000,000	69,700,000	7,000,000	81,700,000	79,800,000	60,650,000	97,600,000	6,200,000
repayment of credit facility	-15,000,000	-13,500,000	-44,200,000	-29,500,000	-18,100,000	-7,800,000	-21,000,000	-21,243,000	-79,357,000	-14,800,000	-10,500,000	0			-17,000,000	0	-55,400,000	-151,800,000	-13,000,000	-30,700,000	-17,250,000	-3,600,000	-95,675,000	-12,900,000
dividends paid to common stockholders, and op unit and ltip unit holders	-15,234,000	-15,269,000	-15,109,000	-14,913,000	-14,900,000	-14,946,000	-14,818,000	-14,820,000	-14,688,000	-14,699,000	-14,641,000	-14,643,000	-14,610,000	-14,526,000	-13,961,000	-13,964,000	-13,260,000	-11,315,000	-10,356,000	-9,913,000	-9,644,000	-10,031,000	-8,004,000	-7,700,000	-7,686,000	-5,781,000	-4,889,000	-4,787,000
dividends paid to preferred stockholders	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,456,000	-1,455,000	-1,457,000	-1,454,000	-1,456,000	-1,455,000	-1,455,000	-1,455,000	-1,456,000	-1,455,000
net cash from financing activities	18,724,000	13,598,000	153,000	9,157,000	-20,701,000	-10,495,000	-15,899,000	-24,503,000	-84,048,000	-19,337,000	-16,038,000	14,529,000	58,325,000	5,591,000	11,532,000	31,660,000	55,580,000	28,932,000	69,420,000	65,057,000	-7,951,000	66,194,000	67,136,000	55,137,000	86,867,000	14,972,000	10,474,000	4,318,000	52,479,000	57,242,000	33,155,209	56,720,453	39,496,904	97,115,434	21,008,907	111,322,478	1,224,242	30,011,987
net increase in cash and cash equivalents and restricted cash	1,638,000	-1,354,000	1,153,000	-29,000	12,000	1,082,000	-888,000	-2,173,000			860,000	-605,000	6,010,000	-4,569,000	890,000	-501,000	970,000	647,000	3,491,000	-6,075,000	-3,539,000	9,691,000	1,359,000	-46,000	2,564,000	-1,535,000
cash and cash equivalents and restricted cash—beginning of period	0	8,942,000	0	0	0	6,724,000	0	0	0	14,455,000	0	0	0	12,759,000	0	0	0	10,753,000		0	0	7,185,000	0	0	0	4,843,000	0	0	0	7,114,000
cash and cash equivalents and restricted cash—end of period	1,638,000	7,588,000	1,153,000	-29,000	12,000	7,806,000	-888,000	-2,173,000	-4,196,000	13,981,000	860,000	-605,000	6,010,000	8,190,000	890,000	-501,000	970,000	11,400,000		-6,075,000	-3,539,000	16,876,000	1,359,000	-46,000	2,564,000	3,308,000	1,021,000	-2,365,000	-1,214,000	7,401,000
supplemental cash flow information:
cash payments for interest	7,758,000	6,568,000	7,047,000	6,942,000	6,176,000	6,407,000	6,859,000	7,004,000	8,147,000	8,139,000	6,367,000	6,206,000	4,788,000	4,258,000	4,400,000	4,125,000	4,580,000	4,602,000	4,568,000	4,423,000	4,093,000	3,823,000	4,595,000	4,166,000	3,807,000	3,714,000	3,971,000	3,514,000	3,347,000	2,245,000	1,817,792	1,448,374	1,649,766	830,068	402,959	2,661,522	697,336	337,609
noncash financing and investing activities:
accrued dividends payable	-4,612,000	16,597,000	-14,000	254,000	124,000	16,156,000	79,000	7,000	194,000	15,854,000	44,000	-149,000	103,000	15,823,000	359,000	58,000	769,000	14,482,000	627,000	562,000			1,621,000	389,000			986,000	169,000	116,000	5,710,000	870,963	1,066,101	49,119	3,651,817	11,251
interest rate swap agreements fair value change recognized in other comprehensive income	-13,117,000	4,900,000	16,670,000	-12,705,000	6,707,000	-4,160,000	5,844,000	2,520,000			2,209,000	-20,356,000	-5,770,000	-17,393,000
ltip units redeemed for common stock	0	67,000		104,000	4,000	205,000
accrued capital expenditures and leasing commissions included in accounts payable and accrued expenses	515,000	1,769,000	470,000	514,000	-504,000	1,946,000
recognition of lease liability related to right of use asset	2,429,000	3,851,000					0	0
gain on sale of investment properties		-1,358,000	-5,765,000	-1,823,000			0	-2,289,000
impairment of investment property
loss on extinguishment of debt
investment in unconsolidated joint venture
advances (made to) repayments received from related parties
payment received on loan made to a tenant											0
net proceeds received from common equity offerings			0								-83,000	0	1,769,000	8,210,000	11,089,000	-22,000	50,143,000	144,312,000	14,951,000	24,532,000			92,699,000	17,148,000	707,000	78,944,000	34,098,000				375
payment for cmbs loan defeasance
payment of debt issuance costs											0	-3,208,000			0	0	-6,103,000	-74,000	-28,000	-1,138,000
op units and ltip units redeemed for common stock							0	0	305,000	122,000	0	0	0	682,000					2,636,000
loan assumed in connection with a facility acquisition											0
op units issued for a property acquisition							0	0
write off of unamortized debt issuance costs from loan defeasance
proceeds from sale of an investment property held in escrow								0
gain on sale of investment property										-485,000	0
net proceeds from sale of investment property										4,175,000	0
repayments received from advances (made to) related parties
payment of debt issue costs							0
accrued capital expenditures included in accounts payable and accrued expenses								-2,199,000	2,134,000	778,000	172,000	-504,000	-144,000	1,841,000	311,000
net decrease in cash and cash equivalents and restricted cash										-474,000																		-2,365,000
interest rate swap agreements fair value change recognized in other comprehensive loss										7,264,000						-1,838,000	-804,000	-3,631,000	-1,432,000	-2,003,000	1,022,000	13,958,000	-3,922,000	1,303,000	3,550,000	2,022,000
accrued management fee due to related party
internalization - cash paid for acquisition of former advisor, net of cash acquired of 559																			0
proceeds from notes payable
accrued common stock offering costs																	-198,000	220,000	-89,000	99,000			247,000	-362,000	194,000	190,000
capitalized preacquisition costs charged to expense															45,000	39,000	60,000	24,000	-36,000	32,000	128,000	7,000	69,000
noncash lease expense
reserve for uncollectible receivables															283,000	0				100,000
accrued management fees due to related party																			0	-2,022,000	20,000	275,000	105,000	38,000	249,000	192,000	38,000	10,000	14,000	17,000	259,904	175,431	1,227	6,438	-306,438	267,147	-60,000	90,000
loans (made to) repayments received from related parties															112,000
cmbs loan assumed in connection with a facility acquisition																			0	0
op units issued for property acquisitions
initial recognition of lease liability related to right of use asset																							0	0	797,000	2,346,000
ltip units and op units redeemed for common stock																168,000					8,585,000	6,890,000		54,000	0	576,000
loans to related parties
loan repayments (made to) received from related parties																		-127,000
payment of accrued common stock offering costs																						-269,000
reserve and write off of uncollectible receivables
other assets																			75,000	-439,000	89,000	28,000	44,000	-191,000	5,000	32,000	86,000	-223,000	11,000	86,000	-122,110
security deposits and other																			909,000	-244,000	-731,000	195,000	-11,000	481,000	1,759,000	-30,000	224,000	-1,124,000	140,000	2,784,000	-78,553	-238,697
loan repayments from (made to) related parties
preacquisition costs
proceeds from note payable																			0
redemption of ltip units																											0	0	-105,000	-158,000
cash and cash equivalents and restricted cash—beginning of year
cash and cash equivalents and restricted cash—end of year
op units issued primarily for property acquisition
loan repayments from related parties
op units issued for property acquisition																								0	0	506,000
loan repayments received from (made to) related party																						5,000
repayment of note payable																						-35,000		-33,000
payments of debt issuance costs																						-44,000
accrued dividend payable																						10,949,000				8,985,000
advisory expense settled in op units																															154,503
net proceeds received from preferred stock offering																															-187,720
repayment of note payable from related party																															0	0
loans repaid to related party
op units issued primarily for property acquisitions
reclassification of common stock offering costs to additional paid-in capital																											271,000				-499
reclassification of preferred stock offering costs to preferred stock balance																															191
amortization of deferred financing costs and other																								349,000	338,000	313,000	313,000
payments of deferred financing costs																								-502,000	-393,000	-29,000		-1,627,000	-370,000	-753,000	-122,308	-515,668	-1,507,861	-769,163	-946,160	0	0	-1,090,079
accrued preacquisition costs for purchase of properties and tenant improvements																								705,000
construction-in-process completed and transferred to real estate investments
loan repayments made to related parties																										-122,000
pre-acquisition costs for purchase of properties																										-211,000	-221,000	139,000	-128,000	246,000	-153,459	-69,232	-5,049	125,740
borrowings repaid to related parties																														-18,000
repayment of note payable from third party																										-35,000
repayment of credit facility borrowings																										-62,800,000
accrued pre-acquisition costs for purchase of properties and construction in process																														271,000
amortization of above (below) market leases																													181,000	113,000	115,030	25,016	-2,846	-8,200
capitalized acquisition costs charged to expense
loans repayments (made to) from related party
payments for tenant improvements																											-521,000	-1,577,000
repayment of convertible debenture, due to related party
proceeds received from notes payable from acquisitions
repayment of notes payable from acquisitions
proceeds received from note payable from related party
proceeds from revolving credit facility																											43,200,000	12,950,000	65,700,000	64,250,000	38,800,000	-18,400,000	15,600,000	101,200,000
repayment of revolving credit facility borrowings
conversion of convertible debenture due to majority stockholder to common stock
tenant improvements completed and transferred to real estate investments
capitalized pre-acquisition costs charged to expense																												86,000
(loans to) repayments from related parties																												31,000
borrowings from related parties
repayment of revolving credit facility																												-3,900,000
interest rate swap fair value change recognized in other comprehensive loss
accrued pre-acquisition costs for purchase of properties and tenant improvements																												-873,000
op units issued for noncash transaction																												0			10,300,000
accrued preferred stock offering costs
amortization of deferred financing costs																													553,000	430,000	383,786	340,637	340,905	158,672				90,241
net proceeds received from follow-on offering
accrued deferred asset costs
accrued deferred public offering costs
reclassification of deferred follow-on offering costs to additional paid-in capital
capitalized deal costs charged to expense																														4,000			2,300	3,150
payments for construction in process																														-133,000
dividends paid to common stockholders, and op and ltip unit holders																														-4,552,000
net increase in cash and cash equivalents																														287,000	-1,667,370				-61,676,861	78,773,188	2,067,523	-8,676,989
restricted cash																															151,705	376,832	-391,393	-1,130,144	-119,890	-118,690	0	-319,499
loans repayments from (made to) related party																															-17,428	-1,956
change in restricted cash																															-117,023	-125,778	-125,778	297,579	-15,678	290,492	300,253	-510,705
loans (repaid to) from related party																															-8,851			-450
(repayment of) proceeds from convertible debenture, due to related party
proceeds from notes payable from acquisitions																																				0	0	41,320,900
proceeds from note payable from related party																																					0	450,000
cash and cash equivalents—beginning of period																															-131	0	0	19,671,131	0	0	0	9,184,270
cash and cash equivalents—end of period																															-1,667,501	-5,257,296	3,677,198	8,356,599	-61,676,861	78,773,188	2,067,523	507,281
payments on notes payable from acquisitions																																				-14,600,986	-92,831	-9,317,351
dividends paid to stockholders																																-3,607,727	-3,603,484	-3,604,037	-3,592,786	0	-121,551	-164,152
accrued capitalized offering costs
loans from related party																																						152,893
payments of deferred initial public offering costs
net decrease in cash and cash equivalents																																	3,677,198	-11,314,532
accrued deferred initial public offering costs
accrued capitalized deal costs
prepaid assets																																						-27,925
loans to related party																																				40	-17,540	-21,500
conversion of convertible debenture due to majority stockholder to shares of common stock																																					0	15,000,000
cash paid for pre-acquisition costs
acquisition of land, buildings, and other tangible and intangible assets and liabilities
net proceeds received from initial public offering																																			-70,351
loan (repayments to) received from related parties
proceeds from convertible debenture, due to related party
repayments of convertible debenture, due to related party
proceeds from notes payable to related parties																																			1,500,000
repayments of notes payable from related parties
proceeds received from revolving credit facility
proceeds from notes payable related to acquisitions
payments on notes payable related to acquisitions
conversion of convertible debenture due to related party to shares of common stock
reclassification of deferred initial public offering costs to additional paid-in capital																																			0
amortization of debt discount																																				62,604
ltip unit compensation expense
accrued expenses																																				-1,509,305	357,531	884,147
purchase of buildings and improvements																																				-30,744,356	0	-37,946,139
loans received from related parties
repayment of notes payable from related parties
conversion of convertible debenture due to zh usa, llc to shares of common stock
loans from related parties
proceeds from note payable to majority stockholder
accounts receivable

We provide you with 20 years of cash flow statements for Global Medical REIT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Global Medical REIT stock. Explore the full financial landscape of Global Medical REIT stock with our expertly curated income statements.

The information provided in this report about Global Medical REIT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.